COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Facilitating API Delivery with Nanoscale Solutions

The July issue of Pharmaceutical Technology highlights nanotechnology with interviews from Young-Ho Song, a research fellow at Pfizer Oncology, and NCL’s Stephan Stern. The article, written by Cynthia Challener, touches on some of the most promising avenues for nanotech—improving the therapeutic potential of existing drugs, resurrecting previously failed drugs, developing generics of current marketed formulations, immunotherapies and gene therapies—and cites the global growth potential of nanomedicines to reach $79 billion in the next seven years.

Read the full article by Cynthia Challener here:

C. Challener, “Facilitating API Delivery with Nanoscale Solutions,” Pharmaceutical Technology 43 (7) 2019.